These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 34905138)

  • 1. Magnetic nanoparticles in theranostics of malignant melanoma.
    Shevtsov M; Kaesler S; Posch C; Multhoff G; Biedermann T
    EJNMMI Res; 2021 Dec; 11(1):127. PubMed ID: 34905138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic treatments for metastatic cutaneous melanoma.
    Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Review of Current and Pipeline Drugs for Treatment of Melanoma.
    Natarelli N; Aleman SJ; Mark IM; Tran JT; Kwak S; Botto E; Aflatooni S; Diaz MJ; Lipner SR
    Pharmaceuticals (Basel); 2024 Feb; 17(2):. PubMed ID: 38399429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014.
    Ascierto PA; Atkins M; Bifulco C; Botti G; Cochran A; Davies M; Demaria S; Dummer R; Ferrone S; Formenti S; Gajewski TF; Garbe C; Khleif S; Kiessling R; Lo R; Lorigan P; Arthur GM; Masucci G; Melero I; Mihm M; Palmieri G; Parmiani G; Puzanov I; Romero P; Schilling B; Seliger B; Stroncek D; Taube J; Tomei S; Zarour HM; Testori A; Wang E; Galon J; Ciliberto G; Mozzillo N; Marincola FM; Thurin M
    J Transl Med; 2015 Nov; 13():374. PubMed ID: 26619946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functionalization of Nanomaterials and Their Application in Melanoma Cancer Theranostics.
    Madamsetty VS; Paul MK; Mukherjee A; Mukherjee S
    ACS Biomater Sci Eng; 2020 Jan; 6(1):167-181. PubMed ID: 33463233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant Melanoma of the Gastrointestinal Tract: Symptoms, Diagnosis, and Current Treatment Options.
    Kohoutova D; Worku D; Aziz H; Teare J; Weir J; Larkin J
    Cells; 2021 Feb; 10(2):. PubMed ID: 33562484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of metastatic malignant melanoma.
    Atallah E; Flaherty L
    Curr Treat Options Oncol; 2005 May; 6(3):185-93. PubMed ID: 15869730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Decade of Success in Melanoma Immunotherapy and Targeted Therapy: What Every Radiologist Should Know.
    Chen M; Smith DA; Yoon JG; Vos D; Kikano EG; Tirumani SH; Ramaiya NH
    J Comput Assist Tomogr; 2022 Jul-Aug 01; 46(4):621-632. PubMed ID: 35675685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival of patients with advanced metastatic melanoma: the impact of novel therapies-update 2017.
    Ugurel S; Röhmel J; Ascierto PA; Flaherty KT; Grob JJ; Hauschild A; Larkin J; Long GV; Lorigan P; McArthur GA; Ribas A; Robert C; Schadendorf D; Garbe C
    Eur J Cancer; 2017 Sep; 83():247-257. PubMed ID: 28756137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.
    Ascierto PA; Agarwala S; Botti G; Cesano A; Ciliberto G; Davies MA; Demaria S; Dummer R; Eggermont AM; Ferrone S; Fu YX; Gajewski TF; Garbe C; Huber V; Khleif S; Krauthammer M; Lo RS; Masucci G; Palmieri G; Postow M; Puzanov I; Silk A; Spranger S; Stroncek DF; Tarhini A; Taube JM; Testori A; Wang E; Wargo JA; Yee C; Zarour H; Zitvogel L; Fox BA; Mozzillo N; Marincola FM; Thurin M
    J Transl Med; 2016 Nov; 14(1):313. PubMed ID: 27846884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple metastases after surgery for a rare vulvar malignant melanoma combined with immunotherapy: a case report.
    Li W; Song J; Sun Y; Cui Z
    J Int Med Res; 2020 Nov; 48(11):300060520965398. PubMed ID: 33203293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New therapeutic options for advanced non-resectable malignant melanoma.
    Stadler S; Weina K; Gebhardt C; Utikal J
    Adv Med Sci; 2015 Mar; 60(1):83-8. PubMed ID: 25596540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applications of nanotechnology for melanoma treatment, diagnosis, and theranostics.
    Chen J; Shao R; Zhang XD; Chen C
    Int J Nanomedicine; 2013; 8():2677-88. PubMed ID: 23926430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic Therapies for Advanced Melanoma.
    Bomar L; Senithilnathan A; Ahn C
    Dermatol Clin; 2019 Oct; 37(4):409-423. PubMed ID: 31466582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic Solid Nanoparticles and Their Counterparts: Recent Advances towards Cancer Theranostics.
    Cerqueira M; Belmonte-Reche E; Gallo J; Baltazar F; Bañobre-López M
    Pharmaceutics; 2022 Feb; 14(3):. PubMed ID: 35335882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant treatment for stage III and IV cutaneous melanoma.
    Gorry C; McCullagh L; O'Donnell H; Barrett S; Schmitz S; Barry M; Curtin K; Beausang E; Barry R; Coyne I
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD012974. PubMed ID: 36648215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current and future roles of targeted therapy and immunotherapy in advanced melanoma.
    Olszanski AJ
    J Manag Care Spec Pharm; 2014 Apr; 20(4):346-56. PubMed ID: 24684639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy for Melanoma.
    Moyers JT; Glitza Oliva IC
    Adv Exp Med Biol; 2021; 1342():81-111. PubMed ID: 34972963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of advanced melanoma: a review of systemic and local therapies in combination with immune checkpoint inhibitors in phase 1 and 2 clinical trials.
    DePalo DK; Tarhini A; Zager JS
    Expert Opin Investig Drugs; 2022 Jan; 31(1):95-104. PubMed ID: 34996314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harnessing the immune system for the treatment of melanoma: current status and future prospects.
    Guennoun A; Sidahmed H; Maccalli C; Seliger B; Marincola FM; Bedognetti D
    Expert Rev Clin Immunol; 2016 Aug; 12(8):879-93. PubMed ID: 27070898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.